[go: up one dir, main page]

FI971272A - Heikennetty rokotus- ja geenisiirtovirus, menetelmä viruksen valmista miseksi ja virusta sisältävä farmaseuttinen koostumus - Google Patents

Heikennetty rokotus- ja geenisiirtovirus, menetelmä viruksen valmista miseksi ja virusta sisältävä farmaseuttinen koostumus Download PDF

Info

Publication number
FI971272A
FI971272A FI971272A FI971272A FI971272A FI 971272 A FI971272 A FI 971272A FI 971272 A FI971272 A FI 971272A FI 971272 A FI971272 A FI 971272A FI 971272 A FI971272 A FI 971272A
Authority
FI
Finland
Prior art keywords
virus
vrna
viral
promoter
progeny
Prior art date
Application number
FI971272A
Other languages
English (en)
Swedish (sv)
Other versions
FI971272A0 (fi
Inventor
Gerd Hobom
Gabriele Neumann
Annette Menke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI971272A0 publication Critical patent/FI971272A0/fi
Publication of FI971272A publication Critical patent/FI971272A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5256Virus expressing foreign proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16141Use of virus, viral particle or viral elements as a vector
    • C12N2760/16143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI971272A 1994-09-30 1997-03-26 Heikennetty rokotus- ja geenisiirtovirus, menetelmä viruksen valmista miseksi ja virusta sisältävä farmaseuttinen koostumus FI971272A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94115505A EP0704533A1 (en) 1994-09-30 1994-09-30 An attenuated vaccination virus, a method to make the virus and a pharmaceutical compositions comprising the virus
PCT/EP1995/003663 WO1996010641A1 (en) 1994-09-30 1995-09-18 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus

Publications (2)

Publication Number Publication Date
FI971272A0 FI971272A0 (fi) 1997-03-26
FI971272A true FI971272A (fi) 1997-05-26

Family

ID=8216345

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971272A FI971272A (fi) 1994-09-30 1997-03-26 Heikennetty rokotus- ja geenisiirtovirus, menetelmä viruksen valmista miseksi ja virusta sisältävä farmaseuttinen koostumus

Country Status (10)

Country Link
US (1) US6524588B1 (fi)
EP (3) EP0704533A1 (fi)
JP (1) JP2000509962A (fi)
AT (1) ATE210727T1 (fi)
AU (1) AU3607695A (fi)
DE (1) DE69524618T2 (fi)
ES (1) ES2165434T3 (fi)
FI (1) FI971272A (fi)
NZ (1) NZ293600A (fi)
WO (1) WO1996010641A1 (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9809666D0 (en) * 1998-05-06 1998-07-01 Isis Innovation Modified viruses
EP1035209A1 (en) * 1999-03-06 2000-09-13 ARTEMIS Pharmaceuticals GmbH Stable recombinant influenza viruses free of helper viruses
US8715940B2 (en) 1999-04-06 2014-05-06 Wisconsin Alumni Research Foundation Method of making recombinant influenza virus
EP2345716B1 (en) * 1999-04-06 2015-01-14 Wisconsin Alumni Research Foundation Recombinant influenza viruses for vaccines and gene therapy
EP1201760A1 (en) * 2000-10-30 2002-05-02 ARTEMIS Pharmaceuticals GmbH Influenza virus vector for human dendritic cells
US20030099670A1 (en) * 2001-02-09 2003-05-29 Gert Hobom Influenza viruses with enhanced transcriptional and replicational capacities
EA200701097A1 (ru) 2004-11-19 2007-10-26 Висконсин Эламни Рисёч Фаундэйшн Рекомбинантные векторы вируса гриппа с тандемными транскрипционными единицами
US20100055672A1 (en) * 2006-05-11 2010-03-04 Geneohm Sciences, Inc. 100% sequence identity detection methods for variable genomes
CN101938981A (zh) * 2008-02-08 2011-01-05 高露洁-棕榄公司 组合物和装置
AU2009212335B2 (en) * 2008-02-08 2011-12-01 Colgate-Palmolive Company Compositions comprising basic amino acid and soluble carbonate salt
AR070593A1 (es) * 2008-02-08 2010-04-21 Colgate Palmolive Co Composiciones efervescentes
RU2519329C2 (ru) * 2008-02-08 2014-06-10 Колгейт-Палмолив Компани Композиции и устройства
BRPI0907103A2 (pt) * 2008-02-08 2016-05-03 Colgate Palmolive Co método para tratamento de dentes sensíveis, composição de selante dental, e, uso de um aminoácido básico em forma livre ou em forma de sal.
BRPI0906464A2 (pt) 2008-02-08 2015-07-14 Colgate Palmolive Co Fio dental, embalagem para armazenar ou dispensar fio dental, e, métodos para produzir fio dental e para tratar um condição
US20100330002A1 (en) * 2008-02-08 2010-12-30 Colgate-Palmolive Company Compositions and methods comprising basic amino acid peptides and proteases
EP2227112B1 (en) * 2008-02-08 2017-01-11 Colgate-Palmolive Company Oral care toothbrush
CN101938984A (zh) * 2008-02-08 2011-01-05 高露洁-棕榄公司 清洁用组合物和方法
TWI451878B (zh) * 2008-02-08 2014-09-11 Colgate Palmolive Co 呈游離或鹽類形式之l‐精胺酸及氟化物用於製造潔齒組成物之用途及潔齒組成物
MX2010005007A (es) * 2008-02-08 2010-05-27 Colgate Palmolive Co Composiciones y metodos para el tratamiento de la xerostomia.
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
US9315464B1 (en) 2013-01-31 2016-04-19 Nant Holdings Ip, Llc Small molecule inhibitors of influenza A RNA-dependent RNA polymerase
WO2015196150A2 (en) 2014-06-20 2015-12-23 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
CN104593330A (zh) * 2015-01-19 2015-05-06 中国科学院微生物研究所 含有a型流感特异性启动子的重组293t细胞及其应用
US11197926B2 (en) 2017-10-25 2021-12-14 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized HA for replication in eggs
EP3840780A1 (en) 2018-08-20 2021-06-30 Wisconsin Alumni Research Foundation Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (ha) protein
WO2020163804A1 (en) 2019-02-08 2020-08-13 Wisconsin Alumni Research Foundation (Warf) Humanized cell line
CN114929269A (zh) 2019-05-01 2022-08-19 威斯康星校友研究基金会(Warf) 用于疫苗开发的改进的流感病毒复制
WO2021041624A2 (en) 2019-08-27 2021-03-04 Yoshihiro Kawaoka Recombinant influenza viruses with stabilized ha for replication in eggs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166057A (en) * 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
US5690937A (en) * 1995-06-05 1997-11-25 Aviron Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene

Also Published As

Publication number Publication date
AU3607695A (en) 1996-04-26
EP0704533A1 (en) 1996-04-03
JP2000509962A (ja) 2000-08-08
NZ293600A (en) 1999-01-28
EP1091000A1 (en) 2001-04-11
DE69524618D1 (de) 2002-01-24
DE69524618T2 (de) 2002-08-14
US6524588B1 (en) 2003-02-25
ATE210727T1 (de) 2001-12-15
ES2165434T3 (es) 2002-03-16
FI971272A0 (fi) 1997-03-26
WO1996010641A1 (en) 1996-04-11
EP0783586B1 (en) 2001-12-12
EP0783586A1 (en) 1997-07-16

Similar Documents

Publication Publication Date Title
FI971272A0 (fi) Heikennetty rokotus- ja geenisiirtovirus, menetelmä viruksen valmista miseksi ja virusta sisältävä farmaseuttinen koostumus
Berkner et al. Generation of adenovirus by transfection of plasmids
Fodor et al. Rescue of influenza A virus from recombinant DNA
Birchmeier et al. Generation of authentic 3′ termini of an H2A mRNA in vivo is dependent on a short inverted DNA repeat and on spacer sequences
EP0512017B1 (en) Vaccines
EP1035209A1 (en) Stable recombinant influenza viruses free of helper viruses
CA2229631C (en) Gene therapy using ovine adenoviral vectors
HUP9900050A1 (hu) Rekombináns adenovírusok, és felhasználásuk adeno-asszociált vírusok (AAV) előállítására, komplementáló sejtvonalak, és az illető adenovírusokat tartalmazó gyógyszerkészítmények
ATE234361T1 (de) Virale amplifikation rekombinanter boten-rna in transgenen pflanzen
CA2406100A1 (en) Dna transfection system for the generation of infectious influenza virus
Ohuchi et al. Human influenza virus hemagglutinin with high sensitivity to proteolytic activation
Flick et al. Mutational analysis of the Uukuniemi virus (Bunyaviridae family) promoter reveals two elements of functional importance
Flick et al. Functional analysis of the noncoding regions of the Uukuniemi virus (Bunyaviridae) RNA segments
KR840007024A (ko) 분자클로닝 및 사람의 릴랙신 유전 정보를 갖는 유전자 배열의 특성화
US20240200042A1 (en) Limited self-replicating mrna molecular system, producing method and use
DE69333529D1 (de) Pflanzenvirus-vektor, plasmid, methode der expression fremder gene und methode zur gewinnung obiger genprodukte
ES2300105T3 (es) Vectores adenoviricos para terapia genica.
Bergmann et al. Mutations in the nonconserved noncoding sequences of the influenza A virus segments affect viral vRNA formation
CN119256086A (zh) 工程化基因效应因子、组合物及其使用方法
CN103215308A (zh) 表达重组人fviii的整合质粒、细胞株及其构建方法和应用
HUP0101355A2 (hu) Fehérjetermelésre és célba juttatására szolgáló genomi szekvenciák
SK137797A3 (en) Recombinant viral vector, pharmaceutical composition containing the same and corresponding transformed cells
KR880014108A (ko) 동물 세포내의 폴리펩타이드에 대한 유전자를 가진 분리된 DNA 조각의 발현을 위한 에피조말 벡터(episomal vector)와 그 제조방법
KR102013586B1 (ko) 유전자 침묵에 내성인 변형된 인간 씨엠브이 프로모터
US20230310555A1 (en) Compositions for genome editing and methods of use thereof

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: HOBOM, GERD

MA Patent expired